Loading…
Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa
Background. HPV types vary by country and HIV status. There are no data on the prevalent HPV genotypes from Cameroon. Methods. We conducted a cross-sectional, observational study on 65 Cameroonian women. Samples were sent for HPV genotyping and Thin Prep analyses. Results. 41 out of 61 samples teste...
Saved in:
Published in: | Infectious Diseases in Obstetrics and Gynecology 2009, Vol.2009, p.111-116 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3 |
---|---|
cites | cdi_FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3 |
container_end_page | 116 |
container_issue | |
container_start_page | 111 |
container_title | Infectious Diseases in Obstetrics and Gynecology |
container_volume | 2009 |
creator | Desruisseau, Andrew J. Schmidt-Grimminger, Delf Welty, Edith |
description | Background. HPV types vary by country and HIV status. There are no data on the prevalent HPV genotypes from Cameroon. Methods. We conducted a cross-sectional, observational study on 65 Cameroonian women. Samples were sent for HPV genotyping and Thin Prep analyses. Results. 41 out of 61 samples tested (67.2%) had HPV subtypes detected. The most common high risk types encountered were: 45 (24.6%) and 58 (21.5%). HIV-positive women were more likely to test positive for any HPV (P=.014), have more than one HPV subtype (P=.003), and to test positive for the high risk subtypes (P=.007). Of those with high risk HPV, HIV-positive women were more likely to have Thin Prep abnormalities than HIV-negative women (P=.013). Conclusions. Oncogenic HPV subtypes 45 and 58 were more prevalent than those subtypes carried in the quadrivalent vaccine. Further studies are needed to assess whether the current vaccine will be effective in this region. |
doi_str_mv | 10.1155/2009/810596 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_a67844d3cd8a42f98597c1d2c9bcf67f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A234055193</galeid><airiti_id>P20151113004_200912_201711010026_201711010026_111_116</airiti_id><doaj_id>oai_doaj_org_article_a67844d3cd8a42f98597c1d2c9bcf67f</doaj_id><sourcerecordid>A234055193</sourcerecordid><originalsourceid>FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3</originalsourceid><addsrcrecordid>eNqFks9v0zAUxyMEYmNw4o4iJoEEhD07_hFfkKpqo5Uq6AG2AwfrNbZbT0lcknRo_z1OM8bKhYMV5-Xj73v-5pskLwl8JITzMwqgzgoCXIlHyTEBVWSglHw87AXLJGPqKHnWddcAUIDgT5MjCkQoUOw4-XG-9cbWPlRhfZsGl86Wl6lv0tn8MluGzvf-xqbYmH3hi13jvnBh295XNr0KtW0GfIq1bUNoPqRXtuvTiWt9ic-TJw6rzr64e54k3y_Ov01n2eLr5_l0ssiQcyIyV5icg2U5SpQE4_zoFFBRGGYUWRnLAWjOKJYEHTfM4QrBsVwIx3PmbH6SzEddE_Bab1tfY3urA3q9L4R2rTHOW1ZWo5AFYyYvTYGMOlVwJUtiaKlWpRPSRa1Po9Z2t6qtKW3Tt1gdiB5-afxGr8ONpgUlUkIUeHsn0Iafu2iGrn1X2qrCxoZdp2XOgDIiSSRf_0Neh13bRKc0UYJLTjmN0OkIrTGO7xsXYtdykNSTaApEB1UeqTcPqI3Fqt90odr1PjTdIfh-BMs2dF1r3f3NCOghTXpIkx7TFOlXD824Z__EJwLvRmDjG4O__H_UFiOMvo25-nvbZdTjhJAcgO1PEDq0kIQAib9eHL5EMC6R_wbtaeHb</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>196575252</pqid></control><display><type>article</type><title>Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa</title><source>Publicly Available Content Database</source><source>Wiley Open Access</source><source>PubMed Central</source><creator>Desruisseau, Andrew J. ; Schmidt-Grimminger, Delf ; Welty, Edith</creator><contributor>Pérez-López, Faustino R.</contributor><creatorcontrib>Desruisseau, Andrew J. ; Schmidt-Grimminger, Delf ; Welty, Edith ; Pérez-López, Faustino R.</creatorcontrib><description>Background. HPV types vary by country and HIV status. There are no data on the prevalent HPV genotypes from Cameroon. Methods. We conducted a cross-sectional, observational study on 65 Cameroonian women. Samples were sent for HPV genotyping and Thin Prep analyses. Results. 41 out of 61 samples tested (67.2%) had HPV subtypes detected. The most common high risk types encountered were: 45 (24.6%) and 58 (21.5%). HIV-positive women were more likely to test positive for any HPV (P=.014), have more than one HPV subtype (P=.003), and to test positive for the high risk subtypes (P=.007). Of those with high risk HPV, HIV-positive women were more likely to have Thin Prep abnormalities than HIV-negative women (P=.013). Conclusions. Oncogenic HPV subtypes 45 and 58 were more prevalent than those subtypes carried in the quadrivalent vaccine. Further studies are needed to assess whether the current vaccine will be effective in this region.</description><identifier>ISSN: 1064-7449</identifier><identifier>EISSN: 1098-0997</identifier><identifier>DOI: 10.1155/2009/810596</identifier><identifier>PMID: 20169094</identifier><identifier>CODEN: IDOGEX</identifier><language>eng</language><publisher>Egypt: Hindawi Limiteds</publisher><subject>Adolescent ; Adult ; Cameroon - epidemiology ; Care and treatment ; Case studies ; Cervical cancer ; Cervical Intraepithelial Neoplasia - pathology ; Cervical Intraepithelial Neoplasia - virology ; Cervix Mucus - virology ; Clinical Study ; Developing countries ; Development and progression ; Diagnosis ; Female ; Genotype ; HIV patients ; HIV Seronegativity ; HIV Seropositivity - complications ; HIV Seropositivity - epidemiology ; Human papillomavirus ; Humans ; LDCs ; Medical research ; Papillomaviridae - classification ; Papillomaviridae - genetics ; Papillomavirus infections ; Papillomavirus Infections - complications ; Papillomavirus Infections - epidemiology ; Polymerase Chain Reaction ; Prevention ; Prevention programs ; Risk Factors ; Studies ; Surveys and Questionnaires ; Uterine Cervical Neoplasms - pathology ; Uterine Cervical Neoplasms - virology ; Vaginal Smears ; Womens health</subject><ispartof>Infectious Diseases in Obstetrics and Gynecology, 2009, Vol.2009, p.111-116</ispartof><rights>Copyright © 2009</rights><rights>COPYRIGHT 2009 John Wiley & Sons, Inc.</rights><rights>Copyright Hindawi Publishing Corporation Fourth Quarter 2009</rights><rights>Copyright © 2009 Andrew J. Desruisseau et al. 2009</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3</citedby><cites>FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/196575252/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/196575252?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,4021,25751,27921,27922,27923,37010,37011,44588,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20169094$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Pérez-López, Faustino R.</contributor><creatorcontrib>Desruisseau, Andrew J.</creatorcontrib><creatorcontrib>Schmidt-Grimminger, Delf</creatorcontrib><creatorcontrib>Welty, Edith</creatorcontrib><title>Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa</title><title>Infectious Diseases in Obstetrics and Gynecology</title><addtitle>Infect Dis Obstet Gynecol</addtitle><description>Background. HPV types vary by country and HIV status. There are no data on the prevalent HPV genotypes from Cameroon. Methods. We conducted a cross-sectional, observational study on 65 Cameroonian women. Samples were sent for HPV genotyping and Thin Prep analyses. Results. 41 out of 61 samples tested (67.2%) had HPV subtypes detected. The most common high risk types encountered were: 45 (24.6%) and 58 (21.5%). HIV-positive women were more likely to test positive for any HPV (P=.014), have more than one HPV subtype (P=.003), and to test positive for the high risk subtypes (P=.007). Of those with high risk HPV, HIV-positive women were more likely to have Thin Prep abnormalities than HIV-negative women (P=.013). Conclusions. Oncogenic HPV subtypes 45 and 58 were more prevalent than those subtypes carried in the quadrivalent vaccine. Further studies are needed to assess whether the current vaccine will be effective in this region.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Cameroon - epidemiology</subject><subject>Care and treatment</subject><subject>Case studies</subject><subject>Cervical cancer</subject><subject>Cervical Intraepithelial Neoplasia - pathology</subject><subject>Cervical Intraepithelial Neoplasia - virology</subject><subject>Cervix Mucus - virology</subject><subject>Clinical Study</subject><subject>Developing countries</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Genotype</subject><subject>HIV patients</subject><subject>HIV Seronegativity</subject><subject>HIV Seropositivity - complications</subject><subject>HIV Seropositivity - epidemiology</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>LDCs</subject><subject>Medical research</subject><subject>Papillomaviridae - classification</subject><subject>Papillomaviridae - genetics</subject><subject>Papillomavirus infections</subject><subject>Papillomavirus Infections - complications</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>Polymerase Chain Reaction</subject><subject>Prevention</subject><subject>Prevention programs</subject><subject>Risk Factors</subject><subject>Studies</subject><subject>Surveys and Questionnaires</subject><subject>Uterine Cervical Neoplasms - pathology</subject><subject>Uterine Cervical Neoplasms - virology</subject><subject>Vaginal Smears</subject><subject>Womens health</subject><issn>1064-7449</issn><issn>1098-0997</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqFks9v0zAUxyMEYmNw4o4iJoEEhD07_hFfkKpqo5Uq6AG2AwfrNbZbT0lcknRo_z1OM8bKhYMV5-Xj73v-5pskLwl8JITzMwqgzgoCXIlHyTEBVWSglHw87AXLJGPqKHnWddcAUIDgT5MjCkQoUOw4-XG-9cbWPlRhfZsGl86Wl6lv0tn8MluGzvf-xqbYmH3hi13jvnBh295XNr0KtW0GfIq1bUNoPqRXtuvTiWt9ic-TJw6rzr64e54k3y_Ov01n2eLr5_l0ssiQcyIyV5icg2U5SpQE4_zoFFBRGGYUWRnLAWjOKJYEHTfM4QrBsVwIx3PmbH6SzEddE_Bab1tfY3urA3q9L4R2rTHOW1ZWo5AFYyYvTYGMOlVwJUtiaKlWpRPSRa1Po9Z2t6qtKW3Tt1gdiB5-afxGr8ONpgUlUkIUeHsn0Iafu2iGrn1X2qrCxoZdp2XOgDIiSSRf_0Neh13bRKc0UYJLTjmN0OkIrTGO7xsXYtdykNSTaApEB1UeqTcPqI3Fqt90odr1PjTdIfh-BMs2dF1r3f3NCOghTXpIkx7TFOlXD824Z__EJwLvRmDjG4O__H_UFiOMvo25-nvbZdTjhJAcgO1PEDq0kIQAib9eHL5EMC6R_wbtaeHb</recordid><startdate>2009</startdate><enddate>2009</enddate><creator>Desruisseau, Andrew J.</creator><creator>Schmidt-Grimminger, Delf</creator><creator>Welty, Edith</creator><general>Hindawi Limiteds</general><general>Hindawi Publishing Corporation</general><general>John Wiley & Sons, Inc</general><general>Hindawi Limited</general><scope>188</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4U-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>2009</creationdate><title>Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa</title><author>Desruisseau, Andrew J. ; Schmidt-Grimminger, Delf ; Welty, Edith</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Cameroon - epidemiology</topic><topic>Care and treatment</topic><topic>Case studies</topic><topic>Cervical cancer</topic><topic>Cervical Intraepithelial Neoplasia - pathology</topic><topic>Cervical Intraepithelial Neoplasia - virology</topic><topic>Cervix Mucus - virology</topic><topic>Clinical Study</topic><topic>Developing countries</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Genotype</topic><topic>HIV patients</topic><topic>HIV Seronegativity</topic><topic>HIV Seropositivity - complications</topic><topic>HIV Seropositivity - epidemiology</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>LDCs</topic><topic>Medical research</topic><topic>Papillomaviridae - classification</topic><topic>Papillomaviridae - genetics</topic><topic>Papillomavirus infections</topic><topic>Papillomavirus Infections - complications</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>Polymerase Chain Reaction</topic><topic>Prevention</topic><topic>Prevention programs</topic><topic>Risk Factors</topic><topic>Studies</topic><topic>Surveys and Questionnaires</topic><topic>Uterine Cervical Neoplasms - pathology</topic><topic>Uterine Cervical Neoplasms - virology</topic><topic>Vaginal Smears</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Desruisseau, Andrew J.</creatorcontrib><creatorcontrib>Schmidt-Grimminger, Delf</creatorcontrib><creatorcontrib>Welty, Edith</creatorcontrib><collection>Airiti Library</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>University Readers</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East & Africa Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ: Directory of Open Access Journals</collection><jtitle>Infectious Diseases in Obstetrics and Gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Desruisseau, Andrew J.</au><au>Schmidt-Grimminger, Delf</au><au>Welty, Edith</au><au>Pérez-López, Faustino R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa</atitle><jtitle>Infectious Diseases in Obstetrics and Gynecology</jtitle><addtitle>Infect Dis Obstet Gynecol</addtitle><date>2009</date><risdate>2009</risdate><volume>2009</volume><spage>111</spage><epage>116</epage><pages>111-116</pages><issn>1064-7449</issn><eissn>1098-0997</eissn><coden>IDOGEX</coden><abstract>Background. HPV types vary by country and HIV status. There are no data on the prevalent HPV genotypes from Cameroon. Methods. We conducted a cross-sectional, observational study on 65 Cameroonian women. Samples were sent for HPV genotyping and Thin Prep analyses. Results. 41 out of 61 samples tested (67.2%) had HPV subtypes detected. The most common high risk types encountered were: 45 (24.6%) and 58 (21.5%). HIV-positive women were more likely to test positive for any HPV (P=.014), have more than one HPV subtype (P=.003), and to test positive for the high risk subtypes (P=.007). Of those with high risk HPV, HIV-positive women were more likely to have Thin Prep abnormalities than HIV-negative women (P=.013). Conclusions. Oncogenic HPV subtypes 45 and 58 were more prevalent than those subtypes carried in the quadrivalent vaccine. Further studies are needed to assess whether the current vaccine will be effective in this region.</abstract><cop>Egypt</cop><pub>Hindawi Limiteds</pub><pmid>20169094</pmid><doi>10.1155/2009/810596</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1064-7449 |
ispartof | Infectious Diseases in Obstetrics and Gynecology, 2009, Vol.2009, p.111-116 |
issn | 1064-7449 1098-0997 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_a67844d3cd8a42f98597c1d2c9bcf67f |
source | Publicly Available Content Database; Wiley Open Access; PubMed Central |
subjects | Adolescent Adult Cameroon - epidemiology Care and treatment Case studies Cervical cancer Cervical Intraepithelial Neoplasia - pathology Cervical Intraepithelial Neoplasia - virology Cervix Mucus - virology Clinical Study Developing countries Development and progression Diagnosis Female Genotype HIV patients HIV Seronegativity HIV Seropositivity - complications HIV Seropositivity - epidemiology Human papillomavirus Humans LDCs Medical research Papillomaviridae - classification Papillomaviridae - genetics Papillomavirus infections Papillomavirus Infections - complications Papillomavirus Infections - epidemiology Polymerase Chain Reaction Prevention Prevention programs Risk Factors Studies Surveys and Questionnaires Uterine Cervical Neoplasms - pathology Uterine Cervical Neoplasms - virology Vaginal Smears Womens health |
title | Epidemiology of HPV in HIV-Positive and HIV-Negative Fertile Women in Cameroon, West Africa |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A17%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidemiology%20of%20HPV%20in%20HIV-Positive%20and%20HIV-Negative%20Fertile%20Women%20in%20Cameroon,%20West%20Africa&rft.jtitle=Infectious%20Diseases%20in%20Obstetrics%20and%20Gynecology&rft.au=Desruisseau,%20Andrew%20J.&rft.date=2009&rft.volume=2009&rft.spage=111&rft.epage=116&rft.pages=111-116&rft.issn=1064-7449&rft.eissn=1098-0997&rft.coden=IDOGEX&rft_id=info:doi/10.1155/2009/810596&rft_dat=%3Cgale_doaj_%3EA234055193%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a5516-f8d350e43a7a71a098af90268d4d91bde5002342ac1af5d4faba0f4366f534fe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=196575252&rft_id=info:pmid/20169094&rft_galeid=A234055193&rft_airiti_id=P20151113004_200912_201711010026_201711010026_111_116&rfr_iscdi=true |